$0.5702
At close: May 15, 11:14 AM EDT
Comments
Loading...
Starpharma Hldgs Analyst Ratings and Price Targets | OTC:SPHRY | Benzinga
Starpharma Hldgs Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Starpharma Hldgs Corp from these most-recent analyst ratings.
Analyst Ratings for Starpharma Hldgs
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Starpharma Hldgs (SPHRY) stock?
There is no price target for Starpharma Hldgs
What is the most recent analyst rating for Starpharma Hldgs (SPHRY)?
There is no analyst for Starpharma Hldgs
When was the last upgrade for Starpharma Hldgs (SPHRY)?
There is no last upgrade for Starpharma Hldgs
When was the last downgrade for Starpharma Hldgs (SPHRY)?
There is no last downgrade for Starpharma Hldgs.
When is the next analyst rating going to be posted or updated for Starpharma Hldgs (SPHRY)?
There is no next analyst rating for Starpharma Hldgs.
Is the Analyst Rating Starpharma Hldgs (SPHRY) correct?
There is no next analyst rating for Starpharma Hldgs.
Browse analyst ratings and price targets on all stocks.
